-
S3 - Nursing 1: Sex-Specific Cardiovascular Risk Modifiers - Pregnancy, Menopause, and Aging
Done
-
S11 - Nursing 4 - Beyond Boundaries: Transmural and Interprofessional Pathways in Chronic Cardiac Management
Done
-
S23 - BWGACHD - A lifetime trajectory for ACHD patients
Done
-
S27 - BWGNICI Hands-on Session : Strain Imaging
Done
-
S5 - Nursing - 2 - Inside the Rhythm: Devices, Leads, and Daily Living
Done
-
S30 - Council on Cardio-oncology - New horizons in cardio-oncology: a paradigm shift in risk, intervention and recovery
Done
-
S17 - BWGBRC - Identification of biomarkers for early detection of cardiovascular diseases
Done
-
S14 - Nursing - 5 - Artificial Intelligence in Cardiac Nursing: Transforming Care Through Technology
Done
-
S8 - Nursing - 3 - Circulatory Challenges: Managing Pressure, Clotting, and Cerebral Events
Done
-
Networking drinkDone
Michiel Algoet, MD, MHA, is a cardiac surgery resident and PhD candidate in Basic Cardiovascular Sciences at UZ Leuven and KU Leuven.
His research addresses myocardial ischemia–reperfusion injury, inflammation, translational cardiovascular models and minimal invasive cardiac surgery.
His work is been supported by an FWO research fellowship and is international recognized through grants.
Michiel Algoet has published in peer-reviewed cardiovascular and cardiothoracic journals and regularly presents at international congresses.
He currently serves as President of the Belgian Young Cardiothoracic Surgeons and is an active member of European and Belgian Cardiothoracic Societies.
Tijs Tournoy obtained his medical degree in 2022 at Ghent University. He is a resident at the Department of Cardiology, UZ Ghent and a PhD student at Ghent University within the Heritable Thoracic Aortic Disease Lab. His research focuses on aging in patients with congenital heart disease. His work explores biological hallmarks of aging in this population, including telomere length, chronic inflammation, and epigenetics, alongside clinical and echocardiographic predictors of aging.
Andreas Verstraete obtained his Master’s degree in Medicine in 2021 at KU Leuven.
After two years of training in internal medicine, he started his PhD in October 2023 within the Departments of Cardiovascular Diseases at UZ Leuven and Cardiovascular Sciences at KU Leuven.
His research addresses the broad field of venous thromboembolism and anticoagulation, with a particular interest in the clinical value of multi-gene panels for the detection of inherited thrombophilia and the characterization of novel genetic variants.
Dr. Federica Valente is a cardiologist at the Pulmonary Vascular Diseases (PVD) and Heart Failure Clinic within the Department of Cardiology at HUB Erasme Hospital in Brussels, where she has been practicing since 2023.
She completed her cardiology training with several interuniversity diplomas in heart failure, advanced heart failure and transplantation, and cardiac imaging. In 2021, she undertook a fellowship in advanced heart failure at Louis Pradel Hospital in Lyon. In 2025, she completed the Postgraduate Course in Heart Failure (PCHF), jointly organized by the University of Zurich and the European Society of Cardiology – Heart Failure Association (ESC-HFA).
In her clinical practice, Dr. Valente focuses primarily on heart failure, cardiac transplantation, cardiomyopathies, non-invasive cardiac imaging, and right heart catheterization.
Jeroen Dauw is a cardiologist with specific expertise in heart failure and cardiac device therapy at AZORG, Aalst (Belgium). His clinical and research work focuses on cardiorenal interactions, congestion management, and device-based therapies. He has published extensively in leading international journals, with several studies awarded and selected for late-breaking presentations at major conferences. Dr. Dauw serves on the Cardiorenal Committee of the Heart Failure Association of the ESC. He is actively involved in international collaborations aimed at improving heart failure care and precision decongestion strategies
